TRT and immune function: what Day 38 check-ins don't tell you

What's this video probably claiming?

Based on the caption, this creator is 38 days into testosterone replacement therapy and using his current experience, specifically staying energetic and maintaining good mood while sick with pneumonia, as evidence that TRT is working. The implicit claim is that testosterone is keeping him functional despite a serious respiratory infection. The hashtags like optimize and hormones reinforce the broader framing common in TRT content: that correcting low testosterone produces measurable, real-world improvements in energy and mood that persist even under physiological stress. He's not making a dramatic medical claim. But the casual attribution, "TRT still has my energy levels up," is doing a lot of work here. It suggests TRT is the explanatory variable for how he feels, during a period when his body is fighting an active infection, when dozens of other variables (sleep, hydration, antibiotics, illness severity, baseline fitness) are equally in play. That's the kind of reasoning that sounds credible in a 30-second video and falls apart under light scrutiny.

What does the science actually show?

The evidence that TRT improves energy and mood in men with confirmed hypogonadism is real, but narrower than most TRT content implies. The Testosterone Trials (Snyder et al., 2016, NEJM), a placebo-controlled study of 790 men with low testosterone, found modest but statistically significant improvements in sexual function and some quality-of-life measures, but energy improvements were inconsistent across the trial's sub-studies. A 2023 meta-analysis by Bhasin et al. in the Journal of Clinical Endocrinology and Metabolism confirmed that TRT improves fatigue scores in hypogonadal men, but effect sizes were moderate, and benefits took 3 to 6 months to stabilize in most participants. At 38 days, he's barely past the initial adjustment phase. As for testosterone and immune function during active infection, the picture gets complicated fast. Testosterone generally has immunosuppressive properties at higher concentrations, not immunoprotective ones. Studies in the journal Endocrinology (Angele et al., 2006) showed supraphysiologic testosterone levels attenuated certain innate immune responses. Replacement-dose TRT in hypogonadal men is a different context, but the "TRT is keeping me strong while sick" framing doesn't have direct clinical backing.

Where does the social media noise diverge from clinical reality?

The TRT content ecosystem on TikTok has a consistency problem: it treats subjective daily experience as clinical data. Feeling good on Day 38 is not evidence that TRT is working in any measurable hormonal sense. Testosterone cypionate or enanthate, the most common TRT formulations, typically take 4 to 8 weeks to reach stable serum levels after dose initiation, and subjective outcomes like energy and mood are notoriously difficult to disentangle from placebo response, lifestyle changes made alongside starting TRT, or simply the psychological effect of feeling like you're doing something proactive about your health. A 2020 randomized trial by Corona et al. in the Journal of Sexual Medicine found that placebo response rates in TRT trials for subjective outcomes like energy and mood ran as high as 30 to 40 percent in some cohorts. Beyond that, "energy levels" during pneumonia recovery is a strange metric. Pneumonia causes fatigue through cytokine release, hypoxia, and inflammatory load. TRT has no established mechanism for counteracting any of those pathways at physiologic replacement doses. Framing resilience during illness as a TRT benefit is a correlation that the science does not support.

What should you actually know?

TRT is a legitimate, FDA-regulated treatment for diagnosed hypogonadism, and when used correctly it does improve quality of life for men with genuinely low testosterone, typically defined as total testosterone below 300 ng/dL with accompanying symptoms. The Endocrine Society's 2018 clinical practice guidelines recommend confirmation with at least two morning serum testosterone measurements before initiating treatment. What TRT is not, based on current evidence, is a general performance enhancer that buffers you from the effects of serious infection. If you're 38 days into TRT and feeling reasonably okay during pneumonia, that's good, but crediting the testosterone specifically requires a level of certainty no honest clinician would claim. Anyone watching this video and thinking "TRT must be worth it because look how well he's doing," should know that pneumonia has a wide severity range, most healthy adults manage it without feeling completely incapacitated, and anecdotal check-ins filmed during illness are not a substitute for labs, a prescribing physician, and a clinical indication. The optimize hashtag crowd rarely emphasizes that part.